Prevention of thromboembolism in rheumatic heart disease

Prevention of thromboembolism in rheumatic heart disease refers to thromboprophylactic management aimed at averting arterial or systemic embolic events, predominantly ischemic strokes, in individuals with chronic cardiac valvular damage caused by prior rheumatic fever Primarily affecting the cardiovascular and neurological systems, this clinical state arises when chronic rheumatic inflammation leads to valvular deformity—most notably mitral stenosis—causing significant left atrial enlargement, b...

Prevention of thromboembolism in rheumatic heart disease refers to thromboprophylactic management aimed at averting arterial or systemic embolic events, predominantly ischemic strokes, in individuals with chronic cardiac valvular damage caused by prior rheumatic fever Primarily affecting the cardiovascular and neurological systems, this clinical state arises when chronic rheumatic inflammation leads to valvular deformity—most notably mitral stenosis—causing significant left atrial enlargement, b...

These hemodynamic and structural disturbances fulfill Virchow’s triad within the cardiac chambers, fostering the formation of intracardiac mural thrombi that can dislodge and occlude distal systemic vasculature